When a public health system succeeds at drawing people in but fails to receive them, the promise of care becomes its own kind of harm. New Zealand's cervical screening programme found this out the hard way: a 2023 rollout of at-home HPV tests brought Māori and Pacific women into the system in meaningful numbers for the first time, only to leave many waiting in a diagnostic bottleneck that the country's colposcopy services were never resourced to absorb. The review released this week is less a story of policy failure than of a recurring human pattern — the gap between the vision of equity and t
NZ cervical screening system 'set up to fail' as HPV test rollout outpaces resources
Between 2018 and 2022, Māori women died from cervical cancer at more than twice the rate of other New Zealanders, highlighting health inequities in screening access and outcomes.